Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Northwest Biotherapeutics (NWBO) Presents at Rodman & Renshaw Conference

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The company has a broad platform technology for DCVax dendritic cell-based vaccines, and its lead product, DCVax-L, is currently in a 348-patient phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. For more information, visit the company’s website

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.